This webinar discusses the evolving landscape of cell and gene therapy manufacturing and quality, highlighting the unique challenges associated with scaling, process control, and regulatory compliance. The speakers explore strategies to build robust manufacturing processes, ensure product consistency, and meet stringent quality expectations. The session also emphasizes the importance of integrated CMC and quality approaches to support successful development and commercialization of advanced therapies.